Global Mobile Cardiac Telemetry Systems Market by Applications (Lead-based and Patch-based), End-uses (Hospitals, Cardiac centers, and Others), and Regions (Asia Pacific, North America, Europe, Latin America, and Middle East & Africa) Forecast, 2021-2028
The global mobile cardiac telemetry systems market is estimated to expand at a considerable CAGR during the forecast period, 2021–2028. Mobile cardiac telemetry (MCT) is a ECG monitoring method which utilizes a compact portable device to keep track of the patient’s cardiac activity. It is an effective technique of monitoring cardiac activity throughout day and night. Cardiac monitoring requires constant examination of the heart via electrocardiography and helps spot irregularities in the working of the heart. Cardiac activity monitoring is an indispensable part of health care diagnosis, owing to the rhythm of the heart being linked with several functions of the human body. Remote cardiac telemetry is a new development in the field, which monitors cardiac activity from remote locations. Some MCT systems provide beat-to-beat analysis by measuring each heartbeat over a 24-hour period.
Market Trends, Drivers, Restraints, and Opportunities:
- Ever-increasing occurrence of cardiovascular and other diseases has emphasized the advantages of mobile cardiac telemetry systems, thus boosting market growth.
- Moreover, physical languor due to sedentary lifestyles along with obesity and smoking has compounded cardiac disorder morbidities, fueling the market for mobile cardiac telemetry systems.
- The COVID-19 pandemic highly affected the medical device industry. Hospitals overstrained with patients are remotely monitoring patients to reduce the patient influx. This factor propels the mobile cardiac telemetry systems market.
- Strict guidelines and product recall due to product failure are anticipated to restrain the revenue growth of the mobile cardiac telemetry systems market.
Scope of the report:
The report on the global mobile cardiac telemetry systems market includes an assessment of the market, size, share, trends, segments, and regional markets. Overview and dynamics have been included in the report.
| Attributes | Details |
| Report Title | Mobile Cardiac Telemetry Systems Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast |
| Base Year | 2020 |
| Historic Data | 2018–2019 |
| Forecast Period | 2021–2028 |
| Segmentation | Applications (Lead-based and Patch-based), End-uses (Hospitals, Cardiac centers, and Others) |
| Regional Scope | Asia Pacific, North America, Latin America, Europe, and Middle East & Africa |
| Report Coverage | Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast |
| Key Players Covered | ACS Diagnostics, BioTelemetry, Inc., iRhythm Technologies, Inc., Medicalgorithmics, S.A., Medicomp Inc, Preventice Solutions, Inc., ScottCare Corporation, Telerhythmics, LLC, and Welch Allyn |
Segment Insights:
Lead-based segment to account for a sizeable market share
On the basis of applications, the market can be segmented into lead-based and patch-based. The lead-based segment accounted for a high revenue share in 2019 and is estimated to grow further during the forecast period, 2021-2028. This can be attributed to the light weight and easy-to-use nature of lead-based MCTs, which are preferred by several patients.
Hospitals segment to grow at a rapid pace
In terms of end-uses, the global mobile cardiac telemetry systems market can be divided into hospitals, cardiac care centers, and others. The hospitals segment is anticipated to dominate the market with a significant revenue share. The growth of the segment can be accredited to the rising number of non-invasive surgeries, the ubiquitous nature of hospitals and easy access to hospitals. Additionally, favorable reimbursement policies are projected to boost the demand during the forecast period, 2021-2028.
North America holds a key share of the global market
Based on regions, the global mobile cardiac telemetry systems market can be classified as North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The North America segment held a key share in the global market in terms of revenue for mobile cardiac telemetry in 2019 and is expected to grow further during the forecast period, 2021-2028. This growth can be attributed to diverse aspects which includes rising geriatric population and increasing healthcare expenditure. According to the Administration for Community Living, a 33% rise in the geriatric population has been observed in the US in the past decade. The market in the region is occupied by several healthcare service providers, which is anticipated to boost the market growth further during the forecast period.
Segments
Segments Covered in the Report:The global mobile cardiac telemetry systems market has been segmented on the basis of
Applications
- Lead-based
- Patch-based
- Hospitals
- Cardiac Care Centers
- Others
- North America
- Europe
- Latin America
- Asia Pacific
- Middle East & Africa
- ACS Diagnostics
- BioTelemetry Inc.
- iRhythm Technologies Inc.
- Medicalgorithmics S.A.
- Medicomp Inc.
- Preventice Solutions Inc.
- ScottCare Corporation
- Telerhythmics LLC
- Welch Allyn
Competitive Landscape
- Major players in the global mobile cardiac telemetry systems market includes ACS Diagnostics, BioTelemetry, Inc., iRhythm Technologies, Inc., Medicalgorithmics, S.A., Medicomp Inc, Preventice Solutions, Inc., ScottCare Corporation, Telerhythmics, LLC, and Welch Allyn. Companies adopt strategies such as investments in R&D, joint ventures, acquisitions, and product launches to increase their market share and market presence.
- In the first half of 2020, Biotelemetry, Inc. extended its MCOT program to COVID-19 patients in several institutions in the US to track QT prolongation linked with hydroxychloroquine medication.
- Some players in the market are trying to develop small devices to withstand competition. In 2019, iRhythm Technologies, Inc. joined hands with Verily Life Sciences to screen, track, and spot atrial fibrillation with the help of data analysis and artificial intelligence.
- In 2018, Biotricity Inc. introduced Bioflux for real-time monitoring. In 2019, Preventice Solutions and GE Healthcare joined hands to offer seamless workflow.
- ADEA Medical AB was acquired by BioTelemetry in line with its long-term expansion roadmap into European market.
2. Assumptions and Acronyms Used
3. Research Methodology
4. Mobile Cardiac Telemetry Systems Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Mobile Cardiac Telemetry Systems Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Mobile Cardiac Telemetry Systems Market - Supply Chain
4.5. Global Mobile Cardiac Telemetry Systems Market Forecast
4.5.1. Mobile Cardiac Telemetry Systems Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Mobile Cardiac Telemetry Systems Market Size (000’ Units) and Y-o-Y Growth
4.5.3. Mobile Cardiac Telemetry Systems Market Absolute $ Opportunity
5. Global Mobile Cardiac Telemetry Systems Market Analysis and Forecast by Applications
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Applications
5.2.2. Y-o-Y Growth Projections by Applications
5.3. Mobile Cardiac Telemetry Systems Market Size and Volume Forecast by Applications
5.3.1. Lead-based
5.3.2. Patch-based
5.4. Absolute $ Opportunity Assessment by Applications
5.5. Market Attractiveness/Growth Potential Analysis by Applications
6. Global Mobile Cardiac Telemetry Systems Market Analysis and Forecast by End Users
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by End Users
6.2.2. Y-o-Y Growth Projections by End Users
6.3. Mobile Cardiac Telemetry Systems Market Size and Volume Forecast by End Users
6.3.1. Hospitals
6.3.2. Cardiac Care Centers
6.3.3. Others
6.4. Absolute $ Opportunity Assessment by End Users
6.5. Market Attractiveness/Growth Potential Analysis by End Users
7. Global Mobile Cardiac Telemetry Systems Market Analysis and Forecast by Region
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Region
7.2.2. Y-o-Y Growth Projections by Region
7.3. Mobile Cardiac Telemetry Systems Market Size and Volume Forecast by Region
7.3.1. North America
7.3.2. Latin America
7.3.3. Europe
7.3.4. Asia Pacific
7.3.5. Middle East and Africa (MEA)
7.4. Absolute $ Opportunity Assessment by Region
7.5. Market Attractiveness/Growth Potential Analysis by Region
7.6. Global Mobile Cardiac Telemetry Systems Demand Share Forecast, 2019-2026
8. North America Mobile Cardiac Telemetry Systems Market Analysis and Forecast
8.1. Introduction
8.1.1. Basis Point Share (BPS) Analysis by Country
8.1.2. Y-o-Y Growth Projections by Country
8.2. North America Mobile Cardiac Telemetry Systems Market Size and Volume Forecast by Country
8.2.1. U.S.
8.2.2. Canada
8.3. Absolute $ Opportunity Assessment by Country
8.4. North America Mobile Cardiac Telemetry Systems Market Size and Volume Forecast by Applications
8.4.1. Lead-based
8.4.2. Patch-based
8.5. Basis Point Share (BPS) Analysis by Applications
8.6. Y-o-Y Growth Projections by Applications
8.7. North America Mobile Cardiac Telemetry Systems Market Size and Volume Forecast by End Users
8.7.1. Hospitals
8.7.2. Cardiac Care Centers
8.7.3. Others
8.8. Basis Point Share (BPS) Analysis by End Users
8.9. Y-o-Y Growth Projections by End Users
8.10. Market Attractiveness/Growth Potential Analysis
8.10.1. By Country
8.10.2. By Product Type
8.10.3. By Application
8.11. North America Mobile Cardiac Telemetry Systems Demand Share Forecast, 2019-2026
9. Latin America Mobile Cardiac Telemetry Systems Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.1.3. Latin America Average Pricing Analysis
9.2. Latin America Mobile Cardiac Telemetry Systems Market Size and Volume Forecast by Country
9.2.1. Brazil
9.2.2. Mexico
9.2.3. Rest of Latin America
9.3. Absolute $ Opportunity Assessment by Country
9.4. Latin America Mobile Cardiac Telemetry Systems Market Size and Volume Forecast by Applications
9.4.1. Lead-based
9.4.2. Patch-based
9.5. Basis Point Share (BPS) Analysis by Applications
9.6. Y-o-Y Growth Projections by Applications
9.7. Latin America Mobile Cardiac Telemetry Systems Market Size and Volume Forecast by End Users
9.7.1. Hospitals
9.7.2. Cardiac Care Centers
9.7.3. Others
9.8. Basis Point Share (BPS) Analysis by End Users
9.9. Y-o-Y Growth Projections by End Users
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.11. Latin America Mobile Cardiac Telemetry Systems Demand Share Forecast, 2019-2026
10. Europe Mobile Cardiac Telemetry Systems Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Europe Average Pricing Analysis
10.2. Europe Mobile Cardiac Telemetry Systems Market Size and Volume Forecast by Country
10.2.1. Germany
10.2.2. France
10.2.3. Italy
10.2.4. U.K.
10.2.5. Spain
10.2.6. Russia
10.2.7. Rest of Europe
10.3. Absolute $ Opportunity Assessment by Country
10.4. Europe Mobile Cardiac Telemetry Systems Market Size and Volume Forecast by Applications
10.4.1. Lead-based
10.4.2. Patch-based
10.5. Basis Point Share (BPS) Analysis by Applications
10.6. Y-o-Y Growth Projections by Applications
10.7. Europe Mobile Cardiac Telemetry Systems Market Size and Volume Forecast by End Users
10.7.1. Hospitals
10.7.2. Cardiac Care Centers
10.7.3. Others
10.8. Basis Point Share (BPS) Analysis by End Users
10.9. Y-o-Y Growth Projections by End Users
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.11. Europe Mobile Cardiac Telemetry Systems Demand Share Forecast, 2019-2026
11. Asia Pacific Mobile Cardiac Telemetry Systems Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Asia Pacific Average Pricing Analysis
11.2. Asia Pacific Mobile Cardiac Telemetry Systems Market Size and Volume Forecast by Country
11.2.1. China
11.2.2. Japan
11.2.3. South Korea
11.2.4. India
11.2.5. Australia
11.2.6. Rest of Asia Pacific (APAC)
11.3. Absolute $ Opportunity Assessment by Country
11.4. Asia Pacific Mobile Cardiac Telemetry Systems Market Size and Volume Forecast by Applications
11.4.1. Lead-based
11.4.2. Patch-based
11.5. Basis Point Share (BPS) Analysis by Applications
11.6. Y-o-Y Growth Projections by Applications
11.7. Asia Pacific Mobile Cardiac Telemetry Systems Market Size and Volume Forecast by End Users
11.7.1. Hospitals
11.7.2. Cardiac Care Centers
11.7.3. Others
11.8. Basis Point Share (BPS) Analysis by End Users
11.9. Y-o-Y Growth Projections by End Users
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.11. Asia Pacific Mobile Cardiac Telemetry Systems Demand Share Forecast, 2019-2026
12. Middle East & Africa Mobile Cardiac Telemetry Systems Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Middle East & Africa Average Pricing Analysis
12.2. Middle East & Africa Mobile Cardiac Telemetry Systems Market Size and Volume Forecast by Country
12.2.1. Saudi Arabia
12.2.2. South Africa
12.2.3. UAE
12.2.4. Rest of Middle East & Africa (MEA)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Middle East & Africa Mobile Cardiac Telemetry Systems Market Size and Volume Forecast by Applications
12.4.1. Lead-based
12.4.2. Patch-based
12.5. Basis Point Share (BPS) Analysis by Applications
12.6. Y-o-Y Growth Projections by Applications
12.7. Middle East & Africa Mobile Cardiac Telemetry Systems Market Size and Volume Forecast by End Users
12.7.1. Hospitals
12.7.2. Cardiac Care Centers
12.7.3. Others
12.8. Basis Point Share (BPS) Analysis by End Users
12.9. Y-o-Y Growth Projections by End Users
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.11. Middle East & Africa Mobile Cardiac Telemetry Systems Demand Share Forecast, 2019-2026
13. Competition Landscape
13.1. Global Mobile Cardiac Telemetry Systems Market: Market Share Analysis
13.2. Mobile Cardiac Telemetry Systems Distributors and Customers
13.3. Mobile Cardiac Telemetry Systems Market: Competitive Dashboard
13.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
13.4.1. ACS Diagnostics
13.4.2. BioTelemetry Inc.
13.4.3. iRhythm Technologies Inc.
13.4.4. Medicalgorithmics S.A.
13.4.5. Medicomp Inc.
13.4.6. Preventice Solutions Inc.
13.4.7. ScottCare Corporation
13.4.8. Telerhythmics LLC&a
The global mobile cardiac telemetry systems market has been segmented on the basis of
Applications
- Lead-based
- Patch-based
- Hospitals
- Cardiac Care Centers
- Others
- North America
- Europe
- Latin America
- Asia Pacific
- Middle East & Africa
- ACS Diagnostics
- BioTelemetry Inc.
- iRhythm Technologies Inc.
- Medicalgorithmics S.A.
- Medicomp Inc.
- Preventice Solutions Inc.
- ScottCare Corporation
- Telerhythmics LLC
- Welch Allyn
- Major players in the global mobile cardiac telemetry systems market includes ACS Diagnostics, BioTelemetry, Inc., iRhythm Technologies, Inc., Medicalgorithmics, S.A., Medicomp Inc, Preventice Solutions, Inc., ScottCare Corporation, Telerhythmics, LLC, and Welch Allyn. Companies adopt strategies such as investments in R&D, joint ventures, acquisitions, and product launches to increase their market share and market presence.
- In the first half of 2020, Biotelemetry, Inc. extended its MCOT program to COVID-19 patients in several institutions in the US to track QT prolongation linked with hydroxychloroquine medication.
- Some players in the market are trying to develop small devices to withstand competition. In 2019, iRhythm Technologies, Inc. joined hands with Verily Life Sciences to screen, track, and spot atrial fibrillation with the help of data analysis and artificial intelligence.
- In 2018, Biotricity Inc. introduced Bioflux for real-time monitoring. In 2019, Preventice Solutions and GE Healthcare joined hands to offer seamless workflow.
- ADEA Medical AB was acquired by BioTelemetry in line with its long-term expansion roadmap into European market.
Our Clients
Related Reports
Some other reports from this category!
